44.13
Precedente Chiudi:
$47.41
Aprire:
$45.7
Volume 24 ore:
2.41M
Relative Volume:
1.07
Capitalizzazione di mercato:
$3.64B
Reddito:
-
Utile/perdita netta:
$-275.16M
Rapporto P/E:
-11.34
EPS:
-3.89
Flusso di cassa netto:
$-221.15M
1 W Prestazione:
-9.03%
1M Prestazione:
-23.60%
6M Prestazione:
+37.73%
1 anno Prestazione:
-10.34%
Springworks Therapeutics Inc Stock (SWTX) Company Profile
Nome
Springworks Therapeutics Inc
Settore
Industria
Telefono
203-883-9490
Indirizzo
100 WASHINGTON BOULEVARD, STAMFORD, CT
Confronta SWTX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
SWTX
Springworks Therapeutics Inc
|
44.13 | 3.64B | 0 | -275.16M | -221.15M | -3.89 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Springworks Therapeutics Inc Stock (SWTX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-11-20 | Iniziato | Evercore ISI | Outperform |
2024-02-05 | Iniziato | Guggenheim | Buy |
2022-12-01 | Iniziato | BofA Securities | Buy |
2021-01-19 | Reiterato | H.C. Wainwright | Buy |
2020-10-29 | Reiterato | H.C. Wainwright | Buy |
2020-05-05 | Iniziato | Barclays | Overweight |
2020-03-19 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
2020-03-04 | Downgrade | H.C. Wainwright | Buy → Neutral |
2020-01-21 | Reiterato | H.C. Wainwright | Buy |
2019-12-04 | Iniziato | H.C. Wainwright | Buy |
2019-10-08 | Iniziato | Cowen | Outperform |
2019-10-08 | Iniziato | Goldman | Buy |
2019-10-08 | Iniziato | JP Morgan | Overweight |
2019-10-08 | Iniziato | Wedbush | Outperform |
Mostra tutto
Springworks Therapeutics Inc Borsa (SWTX) Ultime notizie
BIT Capital GmbH Increases Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Segall Bryant & Hamill LLC Acquires 58,522 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Cibc World Markets Corp Takes $232,000 Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Stock Price Down 2.5%Time to Sell? - MarketBeat
SpringWorks Therapeutics Target of Unusually Large Options Trading (NASDAQ:SWTX) - MarketBeat
Neurofibromatosis Type 2 Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Recursion Pharma, Vivace Therapeutics, Healx Limited, SpringWorks Therapeutics - Barchart
Neurofibromatosis Type 2 Pipeline 2025: Key Companies, MOA, - openPR
Raymond James Financial Inc. Invests $10.53 Million in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
46,895 Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Purchased by Platinum Investment Management Ltd. - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Shares Down 4.8%Should You Sell? - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Short Interest Update - MarketBeat
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week - MSN
FDA’s new and supplemental approvals in February - BioCentury
Bank of New York Mellon Corp Sells 30,986 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
This Is What Whales Are Betting On SpringWorks Therapeutics - Benzinga
SpringWorks Therapeutics and Jewelry Designer Jennifer Fisher Te - GuruFocus.com
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Victory Capital Management Inc. - MarketBeat
High Growth Tech Stocks In The US Market March 2025 - Simply Wall St
How To Trade (SWTX) - Stock Traders Daily
SpringWorks Therapeutics Inc (SWTX) Q4 2024 Earnings Report Prev - GuruFocus.com
SpringWorks Shares Rise More Than 30% in 3 Months: Here's Why - TradingView
SpringWorks Therapeutics, Inc.'s (NASDAQ:SWTX) Shares Climb 26% But Its Business Is Yet to Catch Up - Simply Wall St
Victory Capital Management Inc. Reduces Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
SpringWorks Therapeutics: Promising Launches, Expanding Pipeline, And M&A Buzz - Seeking Alpha
Candriam S.C.A. Cuts Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Traders Buy Large Volume of Call Options on SpringWorks Therapeutics (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) CEO Saqib Islam Sells 49,000 Shares - MarketBeat
SpringWorks Therapeutics Leads Biotech Pack In Weekly Retail Follower Surge: What's Fueling Interest? - MSN
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) COO Badreddin Edris Sells 20,000 Shares - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Shares Down 6%Should You Sell? - MarketBeat
SpringWorks gains after cancelling from investor conference - MSN
Check Out What Whales Are Doing With SWTX - Benzinga
Springworks Therapeutics Inc Azioni (SWTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):